01801.HK
Innovent Biologics, Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 96.60
+0.47%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 58.03x
- P/E 2027E
- 36.50x
- P/E 2028E
- 26.91x
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 116.70x
- PEG TTM
- —
- Price / book
- 3.62x
- Price / sales
- 4.82x
- Price / cash flow
- 7.77x
Enterprise value
- Enterprise value
- HKD 67.1B
- EV / sales
- 3.68x
- EV / EBITDA
- 21.86x
- EV / EBIT
- 30.65x
- Market cap
- HKD 87.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026